Erika Bågeman

451 total citations
14 papers, 286 citations indexed

About

Erika Bågeman is a scholar working on Oncology, Genetics and Dermatology. According to data from OpenAlex, Erika Bågeman has authored 14 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Genetics and 3 papers in Dermatology. Recurrent topics in Erika Bågeman's work include Cancer Risks and Factors (6 papers), BRCA gene mutations in cancer (5 papers) and Hair Growth and Disorders (3 papers). Erika Bågeman is often cited by papers focused on Cancer Risks and Factors (6 papers), BRCA gene mutations in cancer (5 papers) and Hair Growth and Disorders (3 papers). Erika Bågeman collaborates with scholars based in Sweden, United States and Denmark. Erika Bågeman's co-authors include Helena Jernström, Christian Ingvar, Carsten Rose, Tessa Cigler, Anne Moore, Glen Park, Susan A. Melin, Jules T. Mitchel, Laura J. Esserman and Hope S. Rugo and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Erika Bågeman

14 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Bågeman Sweden 8 129 80 73 66 64 14 286
Kyohei Watanabe Japan 10 220 1.7× 12 0.1× 19 0.3× 16 0.2× 147 2.3× 45 441
Yangfeng Ding China 12 37 0.3× 3 0.0× 90 1.2× 15 0.2× 156 2.4× 35 368
Emma Sawyer United Kingdom 5 120 0.9× 26 0.3× 2 0.0× 139 2.1× 184 2.9× 8 416
Kein-Seong Mun Malaysia 9 107 0.8× 3 0.0× 9 0.1× 37 0.6× 96 1.5× 22 259
Jimeng Hu China 12 63 0.5× 26 0.3× 4 0.1× 4 0.1× 227 3.5× 23 422
Yanxia Shi China 11 151 1.2× 10 0.1× 2 0.0× 25 0.4× 93 1.5× 26 354
Mengbo Hu China 11 65 0.5× 29 0.4× 4 0.1× 3 0.0× 119 1.9× 27 309
Ian Laidlaw United Kingdom 5 181 1.4× 2 0.0× 9 0.1× 145 2.2× 115 1.8× 12 351
Y. Lacoursière Canada 4 42 0.3× 9 0.1× 3 0.0× 46 0.7× 52 0.8× 7 354
Lara M. Munín Sánchez Spain 10 173 1.3× 30 0.4× 16 0.2× 80 1.3× 17 302

Countries citing papers authored by Erika Bågeman

Since Specialization
Citations

This map shows the geographic impact of Erika Bågeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Bågeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Bågeman more than expected).

Fields of papers citing papers by Erika Bågeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Bågeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Bågeman. The network helps show where Erika Bågeman may publish in the future.

Co-authorship network of co-authors of Erika Bågeman

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Bågeman. A scholar is included among the top collaborators of Erika Bågeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Bågeman. Erika Bågeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yachnin, Jeffrey, Gustav Ullenhag, Dorte Nielsen, et al.. (2020). Abstract CT145: A first-in-human phase 1 study in patients with advanced and/or refractory solid malignancies to evaluate the safety of ATOR-1015, a CTLA-4 x OX40 bispecific antibody. Cancer Research. 80(16_Supplement). CT145–CT145. 3 indexed citations
2.
Yachnin, Jeffrey, Gustav Ullenhag, Dorte Nielsen, et al.. (2020). A first-in-human phase I study in patients with advanced and/or refractory solid malignancies to evaluate the safety of ATOR-1015, a CTLA-4 x OX40 bispecific antibody.. Journal of Clinical Oncology. 38(15_suppl). 3061–3061. 7 indexed citations
3.
Rugo, Hope S., Paula Klein, Susan A. Melin, et al.. (2017). Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA. 317(6). 606–606. 111 indexed citations
4.
Cigler, Tessa, Pamela Klein, SA Hurvitz, et al.. (2017). Abstract P5-11-17: Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced alopecia. Cancer Research. 77(4_Supplement). P5–11. 2 indexed citations
5.
Rugo, Hope S., Paula Klein, Susan A. Melin, et al.. (2015). Clinical performance of the DigniCap system, a scalp hypothermia system, in preventing chemotherapy-induced alopecia.. Journal of Clinical Oncology. 33(15_suppl). 9518–9518. 6 indexed citations
6.
Bågeman, Erika, et al.. (2010). Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women. Growth Hormone & IGF Research. 20(6). 432–437. 4 indexed citations
7.
Jernström, Helena, Erika Bågeman, Carsten Rose, Jönsson Pe, & Christian Ingvar. (2009). CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients. British Journal of Cancer. 101(11). 1817–1823. 42 indexed citations
8.
Bågeman, Erika, Christian Ingvar, Carsten Rose, & Helena Jernström. (2008). Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status. Cancer Epidemiology Biomarkers & Prevention. 17(4). 895–901. 44 indexed citations
9.
10.
Bågeman, Erika, Christian Ingvar, Carsten Rose, & Helena Jernström. (2007). Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women. British Journal of Cancer. 96(5). 712–717. 10 indexed citations
11.
Jernström, Helena, Erika Bågeman, Christian Ingvar, & Carsten Rose. (2007). Coffee Consumption and the CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status. Malmö University Publications (Malmö University). 1 indexed citations
12.
Klug, Thomas L., Erika Bågeman, Christian Ingvar, Carsten Rose, & Helena Jernström. (2006). Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: A pilot study comparing pre- and post-operative levels. Molecular Genetics and Metabolism. 89(4). 381–389. 12 indexed citations
13.
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyohei Watanabe Breakdown of academic impact, for papers by Yangfeng Ding Breakdown of academic impact, for papers by Emma Sawyer Breakdown of academic impact, for papers by Kein-Seong Mun Breakdown of academic impact, for papers by Jimeng Hu Breakdown of academic impact, for papers by Yanxia Shi Breakdown of academic impact, for papers by Mengbo Hu Breakdown of academic impact, for papers by Ian Laidlaw Breakdown of academic impact, for papers by Y. Lacoursière Breakdown of academic impact, for papers by Lara M. Munín Sánchez
Rankless by CCL
2026